Roche Gets Long-Awaited Green Light For COVID-19 Cocktail In EU

Regulator’s Chief Intervenes To Speed Availability

 
• By Andrew McConaghie
  
Roche
Roche will add the antibody cocktail to its diagnostics and acute therapy Actemra being used to tackle COVID-19.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip